ELEVATE Center: Reduction of Maternal Morbidity from Substance Use Disorder in Utah
Project Number1U54HD113169-01
Former Number1U54DA059137-01
Contact PI/Project LeaderMETZ, TORRI D
Awardee OrganizationUNIVERSITY OF UTAH
Description
Abstract Text
PROJECT SUMMARY ELEVATE CENTER
Accidental drug overdose and suicide were the leading causes of pregnancy-associated death in Utah from
2015-2020, accounting for nearly 40% of all pregnancy-associated deaths over that time period. At-risk
populations, including those in rural settings and those who identify as American Indian or Alaska Native are
disproportionately affected by maternal morbidity. We bring together a transdisciplinary team with expertise in
obstetrics, addiction medicine, simulation training, experiential learning, bias and disparity reduction,
community engagement and implementation science. Together, this collaborative team will establish the
ELEVATE Maternal Health Center of Excellence. ELEVATE is named to encompass our mission to Expand
our reach across Utah and the Mountain West, LEVerage existing infrastructure, And Treat pregnant and
postpartum people with substance use disorder (SUD) who experience disparities to achieve Equity.
In response to our community partners and needs of disproportionately affected populations, we propose three
projects in years 1-5, which will be scaled up and implemented statewide and disseminated nationally in years
6 and 7. Project 1 (CEREMONY) will implement a culturally appropriate and multidisciplinary perinatal care
clinic for individuals with SUD at Sacred Circle Clinic, which is a clinic serving Native mothers. Project 2
(INSPIRE) will develop, implement and test a modular learning intervention, anchored in simulation training, for
interprofessional members of the healthcare team to reduce bias related to SUD in pregnancy. A robust train-
the-trainer curriculum will allow us to implement the program across the state and reach rural communities.
Project 3 (MEMORIES) will refine and test an expanded informant interview tool to ascertain community and
systems contributions to maternal deaths, and the role of discrimination in deaths from SUD. The tool will then
be disseminated nationally to Maternal Mortality Review Committees.
Our ELEVATE Center aims are to: (1) provide integrated and efficient leadership of the three proposed
projects, maximizing coordination with community partners and incorporating research training across all
elements of the ELEVATE Center; (2) mature our existing community partnerships and statewide networks in
order to facilitate future implementation science and effectiveness trials to reduce maternal morbidity and
mortality in Utah, and (3) reduce maternal morbidity in Utah and nationally through implementation of
community-driven interventions and training of health care practitioners.
The ELEVATE Center will rigorously investigate and identify contributors to maternal morbidity and mortality
from SUD with a focus on rural and Native populations. The multipronged approach of the ELEVATE Center
will reduce maternal morbidity from substance use in Utah while training the next generation of scientists
focused on morbidity reduction. Our efforts can ultimately be expanded nationally to address a leading cause
of pregnancy-associated death in the U.S.
Public Health Relevance Statement
PROJECT NARRATIVE ELEVATE CENTER
Substance use and mental health disorders are the leading cause of maternal deaths in the U.S., and
individuals living in rural communities and those who identify as Native American or Alaska Native are
disproportionately affected. The ELEVATE Maternal Health Center of Excellence will complete three research
projects focused on reducing maternal morbidity from substance use disorder. Information gleaned from these
projects will then be disseminated across Utah, and nationally, to improve outcomes for pregnant and
postpartum people with substance use disorder with a broad goal of reducing maternal morbidity.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
009095365
UEI
LL8GLEVH6MG3
Project Start Date
17-August-2023
Project End Date
31-July-2030
Budget Start Date
17-August-2023
Budget End Date
31-July-2024
Project Funding Information for 2023
Total Funding
$1,949,666
Direct Costs
$1,266,017
Indirect Costs
$683,649
Year
Funding IC
FY Total Cost by IC
2023
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$1,949,666
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1U54HD113169-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U54HD113169-01
Patents
No Patents information available for 1U54HD113169-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U54HD113169-01
Clinical Studies
No Clinical Studies information available for 1U54HD113169-01
News and More
Related News Releases
No news release information available for 1U54HD113169-01
History
No Historical information available for 1U54HD113169-01
Similar Projects
No Similar Projects information available for 1U54HD113169-01